Zobrazeno 1 - 7 of 7 pro vyhledávání: '"José Ángel Pineda-Pardo"'
1
Akademický článek
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
Autor: Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau
Publikováno v: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 301-309 (2019)
Abstract Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodege
Externí odkaz: https://doaj.org/article/83200e5382d4469d880f974cffe591af
Zobrazit plný text záznamu
2
Akademický článek
The Default Mode Network is functionally and structurally disrupted in amnestic mild cognitive impairment — A bimodal MEG–DTI study
Autor: Pilar Garcés, José Ángel Pineda-Pardo, Leonides Canuet, Sara Aurtenetxe, Maria Eugenia López, Alberto Marcos, Miguel Yus, Marcos Llanero-Luque, Francisco del-Pozo, Miguel Sancho, Fernando Maestú
Publikováno v: NeuroImage: Clinical, Vol 6, Iss C, Pp 214-221 (2014)
Over the past years, several studies on Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) have reported Default Mode Network (DMN) deficits. This network is attracting increasing interest in the AD community, as it seems to play an importa
Externí odkaz: https://doaj.org/article/6aa94fc971f2467393c470889280cfd8
Zobrazit plný text záznamu
3
A circuit‐based approach to modulate hypersexuality in Parkinson's disease
Autor: David Mata‐Marín, José Ángel Pineda‐Pardo, Mario Michiels, Cristina Pagge, Claudia Ammann, Raúl Martínez‐Fernández, José Antonio Molina, Lydia Vela‐Desojo, Fernando Alonso‐Frech, Ignacio Obeso
Publikováno v: Psychiatry and Clinical Neurosciences. 77:223-232
Impulse-control disorder is a common neuropsychiatric complication in Parkinson's disease under dopamine replacement therapy. Prior studies tested the balance between enhanced desire towards reward and cognitive control deficits, hypothesized to be b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ce0e8493610d287c19b7cdd13ba494
https://doi.org/10.1111/pcn.13523
Zobrazit plný text záznamu
5
A circuit-based approach to repair hypersexuality in Parkinson’s disease
Autor: David Mata-Marín, José Ángel Pineda-Pardo, Mario Michiels, Cristina Pagge, Claudia Ammann, Raúl Martínez-Fernández, José Antonio Molina, Lydia Vela-Desojo, Fernando Alonso-Frech, Ignacio Obeso
One common neuropsychiatric complication in patients with Parkinson’s disease treated with dopamine replacement therapy is impulse control disorders. A proportion of patients under dopamine agonist exhibit excessive desire towards appetitive cues a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9cc951efe7f8f9358a7a3951f3ebcc04
https://doi.org/10.1101/2022.01.25.22269798
Zobrazit plný text záznamu
6
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
Autor: Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau
Publikováno v: Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 301-309 (2019)
Alzheimer's & dementia / Diagnosis, assessment & disease monitoring 11(1), 301-309 (2019). doi:10.1016/j.dadm.2019.01.011
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
van Eimeren, Thilo; Antonini, Angelo; Berg, Daniela; Bohnen, Nico; Ceravolo, Roberto; Drzezga, Alexander; Höglinger, Günter U.; Higuchi, Makoto; Lehericy, Stephane; Lewis, Simon; Monchi, Oury; Nestor, Peter; Ondrus, Matej; Pavese, Nicola; Peralta, María Cecilia; Piccini, Paola; Pineda-Pardo, José Ángel; Rektorová, Irena; Rodríguez-Oroz, María; Rominger, Axel; ... (2019). Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimer's & dementia: Diagnosis, Assessment & Disease Monitorin, 11, pp. 301-309. Elsevier 10.1016/j.dadm.2019.01.011
Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c0a0c06eae74a45e802bf982907e334
https://mediatum.ub.tum.de/doc/1543982/document.pdf
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje